Long Reads: Big Pharma's Toxic Record w/ Nick...

Featuring Emilia González Avalos, Greg Nammacher, and JaNaé Bates Imari on how Minneapolis achieved its fight back against ICE/Border Patrol occupation. A decade building aligned mass movements has made Minneapolis among the best-organized cities in the country. Those carefully b ...  Show more

As this episode was being finalized, the Trump administration was threatening to attack Iran for the second time in less than a year. The threats come against the backdrop of mass protests inside Iran that appear to have been repressed by the state security forces for the time be ...  Show more

Nick Dearden has been an economic justice campaigner for over 20 years, and his attention was on the pharmaceutical industry when Covid-19 hit. But as the world began to sing the praises of pharmaceutical companies, Nick saw an unprecedented PR coup. Giant corporations capitalise ...  Show more

For decades, drugmakers have argued that patents are critical to bringing new drugs to the market. But in 2004, when a promising H.I.V. treatment emerged, Gilead Sciences decided to slow-walk its release to maximize profit on the company’s existing patents.

Rebecca Robbi ...

John Green recently made a video asking Johnson & Johnson not to extend their patent on a tuberculosis drug, which would keep it exclusive and expensive. Dr. Sydnee and Justin talk about how drug patents work, the recent (good) update about bedaquiline specifically, and the ne ...

The second of two episodes this week, taking a deep dive into the pharmaceutical industry.

Big drug companies have won plaudits for their work producing Covid vaccines within a year of the start of the pandemic. How much money are they making from them? And why are vacci ...